2 PX

Drug Profile

2 PX

Alternative Names: 2PX; Topical strontium chloride hexahydrate - SantoSolve AS

Latest Information Update: 14 May 2012

Price : $50

At a glance

  • Originator SantoSolve
  • Class Heavy metals; Non-opioid analgesics
  • Mechanism of Action Ion channel modulators; Phospholipase A2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • No development reported Musculoskeletal pain; Neuropathic pain; Postherpetic neuralgia

Most Recent Events

  • 14 May 2012 No development reported - Phase-II for Postherpetic neuralgia in United Kingdom (Topical)
  • 14 May 2012 No development reported - Phase-III for Neuropathic pain (post-amputation stump pain) in European Union (Topical)
  • 14 May 2012 No development reported - Phase-III for Neuropathic pain (post-amputation stump pain) in Russia (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top